Sherry has over 20 years of experience in strategic consulting, marketing strategy, business innovation, product and franchise optimization, market research and regulatory affairs. Her client engagements include mobile health and telemedicine solutions, innovation in personalized medicine and diagnostics, health IT and hospital solutions,and product portfolio strategies. Her therapeutic areas include neurology, psychiatry, gastroenterology, oncology, anti-infectives, respiratory, nephrology and women’s health. Previously, she was a Director at Amgen, a VP at Migliara/Kaplan (now Kantar Health), an Officer at the FDA, and a Sales Rep for Eli Lilly. She has a BS in Chemistry from The University of Virginia and an MBA from Darden.